ARK Investment Management LLC 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,047,687 7.660% | 35,258 (+1.75%) | Filing |
| 2023-02-10 10:48 am Sale | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,012,429 7.580% | -460,201 (-18.61%) | Filing |
| 2022-02-09 2:03 pm Sale | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,472,630 9.380% | -380,628 (-13.34%) | Filing |
| 2021-11-09 12:03 pm Sale | 2021-10-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,853,258 10.840% | -1,105,761 (-27.93%) | Filing |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 3,959,019 15.310% | 1,463,177 (+58.62%) | Filing |
| 2020-10-09 1:41 pm Purchase | 2020-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,495,842 10.230% | 2,495,842 (New Position) | Filing |